Literature DB >> 8460890

The neurofibromatosis type 1 gene.

D Viskochil1, R White, R Cawthon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8460890     DOI： 10.1146/annurev.ne.16.030193.001151

Source DB:  PubMed          Journal:  Annu Rev Neurosci        ISSN： 0147-006X            Impact factor:   12.449


× No keyword cloud information.
  16 in total

1.  Characterization of Saccharomyces cerevisiae strains expressing ira1 mutant alleles modeled after disease-causing mutations in NF1.

Authors:  R Gil; J M Seeling
Journal:  Mol Cell Biochem       Date:  1999-12       Impact factor: 3.396

2.  Population pharmacokinetics and exposure-response of selumetinib and its N-desmethyl metabolite in pediatric patients with neurofibromatosis type 1 and inoperable plexiform neurofibromas.

Authors:  Stein Schalkwijk; Li Zhou; Sarit Cohen-Rabbie; Lokesh Jain; Tomoko Freshwater; Karen So; Zhongqing He; Ioanna Gioni; Helen Tomkinson; Karthick Vishwanathan; Diansong Zhou
Journal:  Cancer Chemother Pharmacol       Date:  2021-04-26       Impact factor: 3.333

3.  Control of Drosophila perineurial glial growth by interacting neurotransmitter-mediated signaling pathways.

Authors:  J Yager; S Richards; D S Hekmat-Scafe; D D Hurd; V Sundaresan; D R Caprette; W M Saxton; J R Carlson; M Stern
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-21       Impact factor: 11.205

Review 4.  Lessons from the p53 mutant mouse.

Authors:  T Jacks
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

5.  Linkage disequilibrium in the neurofibromatosis 1 (NF1) region: implications for gene mapping.

Authors:  L B Jorde; W S Watkins; D Viskochil; P O'Connell; K Ward
Journal:  Am J Hum Genet       Date:  1993-11       Impact factor: 11.025

Review 6.  Molecular genetics of neurofibromatosis type 1 (NF1).

Authors:  M H Shen; P S Harper; M Upadhyaya
Journal:  J Med Genet       Date:  1996-01       Impact factor: 6.318

7.  Neurofibromatosis type 1 in childhood: correlation of MRI findings with intelligence.

Authors:  E Legius; M J Descheemaeker; J Steyaert; A Spaepen; R Vlietinck; P Casaer; P Demaerel; J P Fryns
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-12       Impact factor: 10.154

8.  Effect of neurofibromatosis type I mutations on a novel pathway for adenylyl cyclase activation requiring neurofibromin and Ras.

Authors:  Frances Hannan; Ivan Ho; James Jiayuan Tong; Yinghua Zhu; Peter Nurnberg; Yi Zhong
Journal:  Hum Mol Genet       Date:  2006-03-02       Impact factor: 6.150

9.  Selumetinib in Children with Inoperable Plexiform Neurofibromas.

Authors:  Andrea M Gross; Pamela L Wolters; Eva Dombi; Andrea Baldwin; Patricia Whitcomb; Michael J Fisher; Brian Weiss; AeRang Kim; Miriam Bornhorst; Amish C Shah; Staci Martin; Marie C Roderick; Dominique C Pichard; Amanda Carbonell; Scott M Paul; Janet Therrien; Oxana Kapustina; Kara Heisey; D Wade Clapp; Chi Zhang; Cody J Peer; William D Figg; Malcolm Smith; John Glod; Jaishri O Blakeley; Seth M Steinberg; David J Venzon; L Austin Doyle; Brigitte C Widemann
Journal:  N Engl J Med       Date:  2020-03-18       Impact factor: 91.245

10.  Familial reciprocal translocation t(17;19) (q11.2;q13.2) associated with neurofibromatosis type 1, including one patient with non-Hodgkin lymphoma and an additional t(14;20) in B lymphocytes.

Authors:  R Fahsold; T Habash; U Trautmann; A Haustein; R A Pfeiffer
Journal:  Hum Genet       Date:  1995-07       Impact factor: 4.132
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.